𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Modulating effect of lonidamine on response to doxorubicin in metastatic breast cancer patients: Results from a multicenter prospective randomized trial

✍ Scribed by Dino Amadori; GiovanniLuca Frassineti; Andrea De Matteis; Giorgio Mustacchi; Antonio Santoro; Salvatore Cariello; Massimo Ferrari; Ottorino Nascimben; Oriana Nanni; Alessandra Lombardi; Emanuela Scarpi; Wainer Zoli

Book ID
110231752
Publisher
Springer US
Year
1998
Tongue
English
Weight
631 KB
Volume
49
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Reply to Effects of Supportive-Expressiv
Reply to Effects of Supportive-Expressive Group Therapy on Survival of Patients with Metastatic Breast Cancer: A Randomized Prospective Trial
✍ David Spiegel; Lisa D. Butler; Janine Giese-Davis; Cheryl Koopman; Elaine Miller πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 35 KB πŸ‘ 1 views

B ased on a very small subsample of 25 estrogen receptor (ER)- negative women with breast cancer, 13 of whom received group therapy, Spiegel et al. 1 conducted an exploratory analysis that found increased survival for these women. They have argued that these women were not protected by hormonal ther

Doxorubicin-paclitaxel : A safe regimen
Doxorubicin-paclitaxel : A safe regimen in terms of cardiac toxicity in metastatic breast carcinoma patients. Results from a European Organization for Research and Treatment of Cancer multicenter trial
✍ Laura Biganzoli; Tanja Cufer; Peter Bruning; Robert E. Coleman; Luc Duchateau; B πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 93 KB πŸ‘ 2 views

## Abstract ## BACKGROUND The potential cardiotoxicy of the doxorubicin‐paclitaxel regimen, when paclitaxel is given shortly after the end of the anthracycline infusion, is an issue of concern, as suggested by small single institution Phase II studies. ## METHODS In a large multicenter Phase III